A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
Background. Colchicine has been used in conditions such as periodic febrile illness, acute pericarditis, and gouty arthritis, all having a common hyperinflammatory response as seen in moderate to severe forms of coronavirus disease 2019 (COVID-19). This project was carried out during the rapid surge...
Saved in:
| Main Authors: | Tegveer Sandhu, Arlene Tieng, Sridhar Chilimuri, Giovanni Franchin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2020/8865954 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing length of hospital stay with colchicine
by: Özlem Karakaş, et al.
Published: (2022-01-01) -
Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial
by: Aryan Mohamadfatih Jalal, et al.
Published: (2022-01-01) -
Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
by: Leonard Chiu, et al.
Published: (2021-01-01) -
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials
by: Chia Siang Kow, et al.
Published: (2022-02-01) -
Profile of Healthcare Workers Infected by Covid-19 Admitted to Udayana University Hospital in April - June 2020
by: Giovanca Verentzia Purnama, et al.
Published: (2024-11-01)